Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US4880626A · kind A · utility
Inventor
Key dates
| Filing date | Aug 17, 1987 |
| Grant date | Nov 14, 1989 |
| Priority date | — |
| Expiry date | Aug 17, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions useful for treating acquired immune deficiency syndrome by once daily administration of substances characteristic of acquired immune deficiency syndrome-afflicted cell (such as human chorionic gonadotropin), and effective fragments and derivatives thereof, in a pharmaceutically effective amount less that the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration. Illustrative of such methods and compositions is the administration of a composition including human chorionic gonadotropin (HCG), a lysate of Staphylococcus aureus, influenza virus vaccine, and fractionated HIV virus, including peptide T.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.